| scholarly article | Q13442814 |
| P50 | author | Michael J Grusby | Q114438980 |
| Mary Collins | Q20084124 | ||
| P2093 | author name string | Takashi Tanaka | |
| Samuel J Goldman | |||
| Debra D Donaldson | |||
| Marion Kasaian | |||
| Bruce A Jacobson | |||
| Joseph P Sypek | |||
| Nancy Wood | |||
| Michael J Eppihimer | |||
| Matthew J Whitters | |||
| Michelle Unger | |||
| JoAnn Witek | |||
| P2860 | cites work | Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-gamma | Q72680200 |
| IL-13 inhibits TNF production but potentiates that of IL-6 in vivo and ex vivo in mice | Q73453145 | ||
| Expression and contribution of endogenous IL-13 in an experimental model of sepsis | Q73458497 | ||
| Prevention of endotoxin-induced lethality in neonatal mice by interleukin-13 | Q73481254 | ||
| The interleukin-13 receptor alpha2 chain: an essential component for binding and internalization but not for interleukin-13-induced signal transduction through the STAT6 pathway | Q73784963 | ||
| Mouse IL-13 enhances antibody production in vivo and acts directly on B cells in vitro to increase survival and hence antibody production | Q77787462 | ||
| IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs | Q77899629 | ||
| The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1 | Q24310131 | ||
| Identification, purification, and characterization of a soluble interleukin (IL)-13-binding protein. Evidence that it is distinct from the cloned Il-13 receptor and Il-4 receptor alpha-chains | Q24310724 | ||
| Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain | Q28281946 | ||
| Interleukin-13: central mediator of allergic asthma | Q28291712 | ||
| cDNA cloning and characterization of the human interleukin 13 receptor alpha chain | Q28296335 | ||
| Modulation of murine macrophage function by IL-13 | Q28505558 | ||
| Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor | Q33633115 | ||
| Immunologic basis of antigen-induced airway hyperresponsiveness | Q33652476 | ||
| The role of IL-13 in helminth-induced inflammation and protective immunity against nematode infections. | Q33711407 | ||
| An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response | Q33853821 | ||
| Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. | Q36261169 | ||
| Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells | Q36364930 | ||
| Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response | Q36370595 | ||
| Interleukin (IL)-4-independent induction of immunoglobulin (Ig)E, and perturbation of T cell development in transgenic mice expressing IL-13. | Q36401457 | ||
| Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction | Q38317997 | ||
| IL-13, IL-4Ralpha, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. | Q39461953 | ||
| Stat6 regulation of in vivo IL-4 responses | Q39529330 | ||
| Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4- and IL-13-dependent signal transduction. | Q40988710 | ||
| Mechanism of suppression of macrophage nitric oxide release by IL-13: influence of the macrophage population | Q41085107 | ||
| Evidence that natural murine soluble interleukin 4 receptors may act as transport proteins | Q41666682 | ||
| Requirement for IL-13 independently of IL-4 in experimental asthma | Q41881960 | ||
| Impaired development of Th2 cells in IL-13-deficient mice. | Q42462315 | ||
| Components of a Stat recognition code: evidence for two layers of molecular selectivity | Q44747920 | ||
| IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-alpha, IFN-gamma, and IL-12 production. | Q45153546 | ||
| Interleukin-13 receptor alpha' but not alpha chain: a functional component of interleukin-4 receptors | Q45886891 | ||
| The immune response to Plasmodium chabaudi malaria in interleukin-4-deficient mice | Q48009150 | ||
| IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity | Q68128207 | ||
| Recombinant soluble murine IL-4 receptor can inhibit or enhance IgE responses in vivo | Q70615366 | ||
| Continuous administration of Il-13 to mice induces extramedullary hemopoiesis and monocytosis | Q71049356 | ||
| In vivo treatment with anti-interleukin-13 antibodies significantly reduces the humoral immune response against an oral immunogen in mice | Q71173525 | ||
| Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice | Q71687715 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | interleukins | Q194908 |
| P304 | page(s) | 703-709 | |
| P577 | publication date | 2003-03-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor alpha 2. | |
| P478 | volume | 197 |
| Q36610541 | A Mutation in IL4RA Is Associated with the Degree of Pathology in Human TB Patients |
| Q39653758 | A common variant associated with asthma, interleukin 13 R130Q, promotes the production of IgE. |
| Q37221291 | A novel and sensitive ELISA reveals that the soluble form of IL-13R-alpha2 is not expressed in plasma of healthy or asthmatic subjects |
| Q36639999 | A role for sex chromosome complement in the female bias in autoimmune disease |
| Q33396838 | Accelerated and progressive and lethal liver fibrosis in mice that lack interleukin (IL)-10, IL-12p40, and IL-13Rα2. |
| Q64236066 | Activin A Signaling Regulates IL13Rα2 Expression to Promote Breast Cancer Metastasis |
| Q92412689 | Allergen presensitization drives an eosinophil-dependent arrest in lung-specific helminth development |
| Q33804200 | Allergen-dependent solubilization of IL-13 receptor alpha2 reveals a novel mechanism to regulate allergy |
| Q35447409 | Altered expression of fibrosis genes in capsules of failed Ahmed glaucoma valve implants |
| Q57461618 | An IL13Rα2 peptide exhibits therapeutic activity against metastatic colorectal cancer |
| Q33883498 | Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis |
| Q33756881 | CXCR3 Requirement for the Interleukin-13-Mediated Up-Regulation of Interleukin-13Rα2 in Pulmonary Fibroblasts |
| Q33325920 | Cationic amino acid transporter-2 regulates immunity by modulating arginase activity |
| Q24648892 | Cellular and molecular mechanisms of fibrosis |
| Q28248430 | Characterization of the interaction between interleukin-13 and interleukin-13 receptors |
| Q37705711 | Chitinase 3-like 1 regulates cellular and tissue responses via IL-13 receptor α2 |
| Q41818218 | Commentary: IL-4 and IL-13 receptors and signaling |
| Q37209512 | Cytokine mediated tissue fibrosis |
| Q42944812 | Decoy receptors in the regulation of T helper cell type 2 responses |
| Q27313373 | Deficiency in Th2 cytokine responses exacerbate orthopoxvirus infection |
| Q36660614 | Distinct roles for IL-13 and IL-4 via IL-13 receptor alpha1 and the type II IL-4 receptor in asthma pathogenesis |
| Q60949690 | Effects of Epithelial IL-13Rα2 Expression in Inflammatory Bowel Disease |
| Q36158461 | Elevated IL-13Ralpha2 in intestinal epithelial cells from ulcerative colitis or colorectal cancer initiates MAPK pathway |
| Q35606790 | Extracellular and intracellular decoys in the tuning of inflammatory cytokines and Toll-like receptors: the new entry TIR8/SIGIRR. |
| Q37791685 | Fibrosis and immune dysregulation in systemic sclerosis |
| Q35852270 | Fibrotic disease and the T(H)1/T(H)2 paradigm |
| Q36765830 | Functional importance of regional differences in localized gene expression of receptors for IL-13 in murine gut. |
| Q29547479 | Genes that mediate breast cancer metastasis to lung |
| Q42022714 | IL-12-STAT4-IFN-gamma axis is a key downstream pathway in the development of IL-13-mediated asthma phenotypes in a Th2 type asthma model |
| Q49710647 | IL-13 -1112 polymorphism and periodontitis susceptibility: a meta-analysis. |
| Q30448616 | IL-13 R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammation |
| Q39793327 | IL-13 and adenosine: partners in a molecular dance? |
| Q24597767 | IL-13 receptor alpha 2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasis |
| Q36909673 | IL-13 receptor isoforms: breaking through the complexity |
| Q37333077 | IL-13 receptor α2 contributes to development of experimental allergic asthma |
| Q36527952 | IL-13 receptor α2-arginase 2 pathway mediates IL-13-induced pulmonary hypertension |
| Q33654576 | IL-13R alpha 2 membrane and soluble isoforms differ in humans and mice |
| Q35995705 | IL-13Ralpha2 and IL-10 coordinately suppress airway inflammation, airway-hyperreactivity, and fibrosis in mice |
| Q35043426 | IL-13Rα1 expression on β-cell-specific T cells in NOD mice |
| Q34610797 | IL-13Rα2 has a protective role in a mouse model of cutaneous inflammation |
| Q37264739 | IL-13Rα2 uses TMEM219 in chitinase 3-like-1-induced signalling and effector responses |
| Q38758144 | IL-17A enhances IL-13 activity by enhancing IL-13-induced signal transducer and activator of transcription 6 activation |
| Q26859510 | IL-4 and IL-13 signaling in allergic airway disease |
| Q36926747 | Identification of interleukin-13 receptor alpha2 chain overexpression in situ in high-grade diffusely infiltrative pediatric brainstem glioma |
| Q35884223 | Immunopathogenesis of schistosomiasis |
| Q54707049 | Interferon-gamma inhibits STAT6 signal transduction and gene expression in human airway epithelial cells. |
| Q34787194 | Interleukin-13 (IL-13)/IL-13 receptor alpha1 (IL-13Ralpha1) signaling regulates intestinal epithelial cystic fibrosis transmembrane conductance regulator channel-dependent Cl- secretion. |
| Q37580214 | Interleukin-13 receptor α2 is associated with poor prognosis in patients with gastric cancer after gastrectomy |
| Q35644889 | Interleukin-13: a key mediator in resistance to gastrointestinal-dwelling nematode parasites |
| Q37239764 | Interleukin-4, interleukin-13, signal transducer and activator of transcription factor 6, and allergic asthma |
| Q36711467 | Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease. |
| Q37433301 | Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury |
| Q37137670 | Lysophosphatidic acid induces interleukin-13 (IL-13) receptor alpha2 expression and inhibits IL-13 signaling in primary human bronchial epithelial cells |
| Q37163250 | Matrix metalloproteinase 8 contributes to solubilization of IL-13 receptor alpha2 in vivo |
| Q90031809 | Mechanisms of Dupilumab |
| Q36087549 | Model-Based Characterization of Inflammatory Gene Expression Patterns of Activated Macrophages. |
| Q27660192 | Molecular Basis for Shared Cytokine Recognition Revealed in the Structure of an Unusually High Affinity Complex between IL-13 and IL-13Rα2 |
| Q39084322 | Negative Regulation of Type 2 Immunity |
| Q35605442 | New targets for allergic rhinitis--a disease of civilization |
| Q35951827 | Opposing roles for IL-13 and IL-13 receptor alpha 2 in health and disease |
| Q44785863 | P-selectin suppresses hepatic inflammation and fibrosis in mice by regulating interferon gamma and the IL-13 decoy receptor |
| Q38003659 | Pathogenesis of severe asthma. |
| Q36370595 | Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response |
| Q36232198 | Regulation of inflammation by interleukin-4: a review of "alternatives" |
| Q46702836 | Requirements for the natural killer cell-mediated induction of IgG1 and IgG2a expression in B lymphocytes |
| Q36617133 | Role of interleukin-13 in cancer, pulmonary fibrosis, and other T(H)2-type diseases |
| Q34087045 | Schistosomiasis-induced experimental pulmonary hypertension: role of interleukin-13 signaling |
| Q91715383 | Scratching Counteracts IL-13 Signaling by Upregulating the Decoy Receptor IL-13Rα2 in Keratinocytes |
| Q36229334 | Semaphorin 7A plays a critical role in TGF-beta1-induced pulmonary fibrosis |
| Q89110163 | Serum level of interleukin-13 receptor alpha 2 in infants with biliary atresia - is it of value? |
| Q36296731 | Site-specific gene expression profiling as a novel strategy for unravelling keloid disease pathobiology |
| Q42739851 | Targeting IL-4/IL-13 signaling to alleviate oral allergen-induced diarrhea |
| Q35937934 | Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis |
| Q35294155 | Th2 Cytokines and Atopic Dermatitis |
| Q90058354 | The IL-13-OVOL1-FLG axis in atopic dermatitis |
| Q34682153 | The IL-21 receptor augments Th2 effector function and alternative macrophage activation |
| Q92187895 | The Intriguing Role of Interleukin 13 in the Pathophysiology of Asthma |
| Q24633658 | The immune pathogenesis of scleroderma: context is everything |
| Q33571172 | The phenotype of murine wound macrophages |
| Q35942450 | Therapeutic targeting of IL-4- and IL-13-responsive cells in pulmonary fibrosis |
| Q38671207 | Tricellulin is regulated via interleukin-13-receptor α2, affects macromolecule uptake, and is decreased in ulcerative colitis. |
| Q36946566 | Tuning sensitivity to IL-4 and IL-13: differential expression of IL-4Ralpha, IL-13Ralpha1, and gammac regulates relative cytokine sensitivity |
| Q38424752 | Type 2 cytokines: mechanisms and therapeutic strategies |
Search more.